Capture-recapture method for estimating annual incidence of imported dengue, France, 2007-2010.
During 2010, the first 2 known cases of autochthonous dengue fever were diagnosed in persons in metropolitan France (4), which comprises continental France and the island of Corsica, located southeast of mainland France (Figure 1). Two cases were also reported in Croatia during 2010 (5), demonstrating that local transmission in continental Europe is a reality. Accordingly, in the context of implementing appropriate public health measures, dengue surveillance systems should be able to estimate the incidence of imported symptomatic cases, describe their geographic distribution in areas already or potentially colonized by the competent vector, and identify the countries where infection occurred. Using a capture-recapture method, we estimate the annual incidence of imported dengue cases and the completeness of the existing surveillance systems in metropolitan France during 2007-2010.
Dengue Surveillance Systems
As of 2010, the Ae. albopictus mosquito was designated as permanently established in 6 southeast departments (administrative districts) in metropolitan France as follows: Alpes-Maritimes (2004), the 2 departments that comprise Corsica, Haute-Corse (2006) and Corse-du-Sud (2007), Var (2007), Bouches-du-Rhone (2009), and Alpes-de-Haute-Provence (2010). Entomological surveillance, based on data from the monitoring of ovitraps (3), enabled information on distribution of this mosquito to be updated within a few weeks. In addition to entomologic surveillance, since 2006, health authorities in France have implemented 3 complementary epidemiologic surveillance systems to identify new dengue and chikungunya infections: a notifiable diseases system that relies on mandatory notification, a laboratory-based surveillance system that operates at the national level, and an enhanced surveillance system, activated each year during May-November in the departments where the Ae. albopictus mosquito is established (3).
The notifiable diseases system requires mandatory notification by practitioners and biologists to collect clinical and biological information about recent symptomatic dengue cases. Notifiable cases are defined by recent fever (within 7 days of medical examination) associated with pain (headache, arthralgia, myalgia, low back pain, or retro-orbital pain) and positive test results for 1 of the following biologic results indicative of dengue infection: reverse transcription PCR (RT-PCR), nonstructural protein 1 [NS1] antigenic test, or IgM serologic analysis. Notification is centralized by the French Institute for Public Health Surveillance for the purpose of epidemiologic analysis. It has been shown that mandatory notification systems lack completeness (of unknown magnitude) and representativeness, and overrepresent hospitalized case-patients (6), leading to unequal probability of being included in a sample (catchability) (7) of dengue cases.
The laboratory-based national surveillance system is a voluntary network that comprises 6 specialized laboratories that monitor the trends of dengue diagnosis (8). Dengue cases are defined by positive RT-PCR, NS1 or IgM serologic test results, regardless of clinical signs. These biologic tests are only to be prescribed when a patient has suggestive symptoms. They are reported weekly to the French Institute for Public Health Surveillance. A survey during 2006 showed that this laboratory network aggregated =85% of the biologic diagnoses of dengue performed in metropolitan France (9).
The enhanced surveillance system is implemented in the departments where the vector is established, during its period of activity from May 1-November 30 each year. Unlike mandatory notification, the basis of enhanced surveillance is the immediate reporting of all clinically suspected cases of dengue fever by practitioners to the regional health authorities. This facilitates accelerated biologic confirmation by the national reference laboratory for arboviruses and, when appropriate, the rapid implementation of local control measures such as perifocal vector control activities and active case finding (3,4).
The 3 surveillance systems are obviously interconnected. For example, during the period of vector activity, dengue cases obtained from mandatory notification or from the laboratory network are immediately reported by the French Institute for Public Health Surveillance to the regional officers supervising the enhanced surveillance system.
A person with an imported case was defined as having traveled in an area where the dengue virus circulates within the previous 15 days before the onset of symptoms. As no substantial local transmission cycle occurred during the study period, all cases without patient information on travel history were considered imported cases.
Strategy for Statistical Analysis
We used the capture-recapture method to estimate the incidence of imported dengue cases in metropolitan France during 2007-2010. By identifying common cases from several systems, this method provides an estimate of the number of cases not captured by any data sources. Consequently, the total number of cases and the capture probabilities of cases within each source can be estimated. To identify common cases, we checked the 3 data sources to find the patient's date of birth, sex, and postal code of residence or of the laboratory where blood samples were collected, and the date of blood sampling. We faced 2 main obstacles to using the capture-recapture method. First, 1 of the 3 data sources, the enhanced surveillance system, operates in a limited area during 7 months each year. This obstacle restricted the possibility of comparing the 3 sources for the analysis. Second, the functional interrelationships between the 3 dengue surveillance systems appear to be limitations to the use of the standard 2-source capture-recapture methods and need to be quantified. We therefore conducted the analysis in 2 steps.
First, dependencies between sources were statistically evaluated following suggestions of Wittes et al. (10,11). The odds ratio implemented with the capture-recapture technique, developed by Wittes et al., is an estimate of the increased probability of a dengue case being reported in a first source when it is also reported in a second source. To investigate the relationship between these sources, the analysis is restricted to cases identified by a third source. The dependence analysis of the sources was restricted to the year 2010 because of an insufficient number of dengue cases before this date. Figure 2 shows the distribution among the 3 surveillance systems of the 199 biologically confirmed dengue cases detected during May 1-November 30, 2010, in the 6 departments of southeast France where the mosquito was established. Table 1 details the calculation of statistical interdependence of the 3 sources. The enhanced surveillance system is highly dependent on both the mandatory notification and the laboratory network. In contrast, mandatory notification and the laboratory network are systems that do not seem to be substantially interdependent; accordingly, we retained only these 2 reporting mechanisms to estimate the annual dengue incidence.
Second, the capture-recapture method was applied to these 2 national-level sources by using 2 estimators of population size: the Chapman-Seber (CS) and the Chao estimates. The CS estimator (12,13) is a commonly used formula and is considered unbiased. This formula uses the hypotheses of independence between sources and equal catchability by each source. Instead, it has been shown recently that Chao's estimator, as formulated by Brittain, is less biased than the CS estimator when there is dependence between sources or unequal catchability of cases (14). Therefore, in this study, we gave priority to the results obtained by using Chao's estimator.
For both estimators, the 95% CIs associated with population size estimates were calculated with the log-transformation suggested by Burnham and used by Chao (15,16). The corresponding completeness values and their 95% CIs, obtained by using Monte-Carlo simulations, were calculated for mandatory notification, for the laboratory network, and for the combined surveillance systems.
Stratification was made for geographic areas where the Ae. albopictus mosquito was established versus other areas and by period of the year (vector activity period versus the rest of the year) to take into account and reduce the potential inequality in catchability. The total variance was calculated by adding the variance of each stratum. To acquire an understanding of the general shape of the curve of monthly number of cases and to compare it with that obtained for the French West Indies, we used the CS estimator with stratification according to geographic area, as many zero values precluded using the Chao estimator.
During 2007-2010 in metropolitan France, 773 cases of dengue were reported by mandatory notification, 3,192 by the laboratory network, and 180 by the enhanced surveillance system. A total of 3,432 distinct cases were reported by the 3 sources, distributed throughout the French departments (Figure 1). Of these cases, 3,423 were reported by 1 of the 2 national level sources: mandatory notification or the laboratory network. The male:female sex ratio of the patients was 0.99:1, and the median age of the patients was 41 years. Positive biologic diagnosis of dengue infection was made by IgM serology (83%) and by an antigenic method (17%, RT-PCR: 13% and NS1 test: 4%). For 1,204 cases (35%), anamnestic and biologic information was sufficient to determine the viremic status of the patients in metropolitan France. Among them, 48.5% were biologically viremic (positive RT-PCR or NS1 test), 47.8% were potentially viremic (the delay between the onset of symptoms and their subsequent return journey to France was <8 days) and 3.7% had data which were not compatible with the viremic stage (viremia delay had exceeded 7 days). Viremia usually occurs between the day before the onset of symptoms and the seventh day after.
The following additional clinical and biological information was available for 718 of the 773 cases of dengue reported by the mandatory notification system. Of the 718 patients, hemorrhagic symptoms were reported for 134 (19%) during the 4-year period. Eight (1%) of these had severe hemorrhagic symptoms (defined at the time of the study as tourniquet test, mucocutaneous bleeding, bleeding from puncture sites, or visceral bleeding). Of the patients for whom specific information was available, 51% (330/652) had thrombocytopenia (platelets [less than or equal to] 100,000/mL) and 47% (323/683) were hospitalized.
Annual Incidence of Dengue Cases and Completeness of Surveillance Systems
Table 2 shows the total number of imported dengue cases in France during the study period: the annual number of cases estimated from mandatory notification and the laboratory network systems after stratification by area where the Ae. albopictus mosquito was established, and by the vector activity period. Using the Chao estimator, we calculated the global number of dengue cases to be 8,374 (95% CI 7,543-9,371) during the 4-year period; the estimated annual incidences were 2,109 in 2007, 751 in 2008, 1,057 in 2009, and 4,456 in 2010 (Table 2). These figures were much lower when we used the CS estimator: the global number of dengue cases was estimated at 4,818 during the 4-year period, 1.7 x lower than that estimated by using the Chao estimator (Table 3).
During the period of vector activity (May-November), the estimated number of dengue cases was 39 (95% CI 26-87) for 2007 and 18 (95% CI 14-37) for 2008 in the 4 departments where the Ae. albopictus mosquito was established at that time; the estimated number was 36 (95% CI 24-79) for 2009 and 234 (95% CI 216-264) for 2010, when a fifth and sixth department, respectively, became affected (Table 2). Dengue cases which occur in these areas during the vector activity period have potential public health implications, given the risk for local transmission by viremic persons.
During 2007-2010, among the 327 estimated dengue cases that occurred in the areas where the vector was established and during its period of activity, 83 (25%) were not detected by either of the 2 national level surveillance systems. The enhanced surveillance system detected 85% of the 199 observed cases (Figure 2) and 73% of the 234 estimated cases in 2010. This system helped to catch a few of the additional cases in 2010 (9 among 199 cases, 4.5%) which were not detected by either the mandatory notification or laboratory network surveillance systems.
Finally, among the 199 patients in whom dengue was detected in southeast France during May-November 2010, 93 (47%) had viremic dengue infections, 64 (32%) were potentially viremic, and 13 (7%) were not viremic. There was not sufficient information for the remaining 29 patients (15%) to enable classification. Among the biologically and potentially viremic patients, the mean estimated duration of viremia while they were in metropolitan France was 6 days.
The completeness of the 2 surveillance systems differed greatly; completeness was much higher for the laboratory network (Table 2). Using the Chao estimator, we estimated the completeness at 3% in 2007 and 13% in 2010 for the mandatory notification surveillance system (9.2% for the 4-year period). We estimated completeness to be an average of [approximately equal to] 4 times higher for the laboratory network: 18% in 2007 and 48% in 2010 (37.8% for the 4-year period). Furthermore, for both surveillance systems, completeness was much higher in areas where the competent vector was established (20.3% for mandatory notification and 57.3% for the laboratory network over the 4-year period) than in other areas (8.6% and 37.1%, respectively), and also much higher during the vector activity period (12.5% and 44.2%, respectively) than during the rest of the year (3.4% and 25.3%, respectively) (Table 4). For the 4-year period, these figures were 32% and 69%, respectively, in Aedes spp.-infested areas during May-November (Table 2). The combination of the 2 surveillance systems increased the completeness compared with the use of the laboratory network alone, but this increase was limited: [approximately equal to] 2% to 4% (Table 4). Globally, the combined completeness was [approximately equal to] 40% for the 4-year period.
Geographic Area of Acquisition of Dengue Infection and Influence of Epidemics in French West Indies
Information on the country of acquisition of dengue infection was available for 1,335 patients (this information was available for mandatory notification and for 3 of the 6 laboratories). Dengue was acquired mainly from 2 geographic areas: the Caribbean and Southeast Asia, which represented 61% and 17% of cases, respectively, over the 4-year period (Table 5). In the Caribbean, the most frequent areas of acquisition (59% of all reported cases) were the French West Indies including Martinique, Guadeloupe, Saint-Barthelemy, and Saint-Martin. In Southeast Asia, dengue fever was primarily acquired in Thailand (7% of all cases) and Indonesia (5%).
In 2007 and 2010, respectively, 34% (37/109) and 71% (682/956) of all cases imported to France were acquired in Guadeloupe (19% in 2007, 41% in 2010) and in Martinique (14% in 2007, 30% in 2010); on each of the 2 islands, dengue epidemics affected nearly 20,000 persons in 2007 and 40,000 in 2010 (17,18). Figure 3 shows the monthly number of dengue cases estimated during 2007-2010 in metropolitan France (estimation from the 2 national sources by using capture-recapture with CS estimator) and in Guadeloupe and Martinique (estimation by regional health authorities from clinically suspected cases within the sentinel network of physicians). The curves roughly overlap, especially during epidemics in the French West Indies. More precisely, the peaks of imported cases in metropolitan France coincide with those of epidemics which occurred in the French West Indies, particularly for the year 2010.
In this study, we estimated that >8,300 cases with laboratory evidence of recent dengue infection were imported into metropolitan France during 2007-2010. Approximately 4,500 of them occurred in 2010; this high number was mainly attributed to epidemics of unusually intense and long duration in the French West Indies (19). A correlation between a substantial number of imported cases of disease in metropolitan France and an intense epidemic in French overseas territories was observed with the dengue epidemic in the French West Indies in 2001 (20) and with the chikungunya epidemic on Reunion Island in 2006 (21). A similar contemporary association was observed in Germany, where an increase in imported dengue cases during 2002 was directly linked to an epidemic in Brazil (22).
An estimated 230 cases occurred during May-November 2010 in the 6 southeast departments of France where the Ae. albopictus mosquito was established, and >90% of the infected persons may have been viremic. The increase in the number of imported cases in southeast France and the high vector density in some urban areas were major factors in the emergence of a local transmission cycle. Two cases of autochthonous dengue fever were reported in the Alpes-Maritimes Department in September 2010 (4).
The capture-recapture method which we applied to estimate the incidence of imported dengue cases is widely used in epidemiologic surveillance studies when several sources of data are available (23). Several assumptions must be checked when using this method (23,24) to avoid biases. Among these, independence between sources and equal catchability of cases by each source, which are interdependent concepts (7), are of great importance. When log-linear modeling is used, the availability of at least 3 sources ensures that the dependence between sources and the unequal catchability when estimating the true number of cases (24,25) can be taken into account. When only 2 sources of data are available, as is the case for dengue surveillance in metropolitan France at the national level, alternative estimators seem worthwhile. In our study, the alternative used was the Chao estimator which relaxes the assumption that sources are independent, and provides more reliable estimates when the differences between the identifying probabilities of the 2 sources are large (26,27). In contrast, with increasing dependencies between sources, the commonly used CS estimator underestimates the true number of cases (14). This underestimation may explain the differences we found between the 2 estimates.
Furthermore, we reduced unequal catchability by stratifying the results by period of year and geographic area. Other factors associated with unequal catchability should be taken into consideration, but it was not possible to do so comprehensively in our study. In particular, patients with severe disease may have had a higher probability of being captured by surveillance systems, which would lead to an underestimation of dengue infections (28). Conversely, the risk for false positives when using IgM detection for dengue diagnosis may have led to an overestimation of this number.
As in other countries, the dengue surveillance systems in France aim to identify symptomatic patients. The proportion of asymptomatic or mildly symptomatic dengue infections fluctuates within endemo-epidemic countries (29) and equals [approximately equal to] 75% (29,30) of all dengue infections. Our estimate, based on symptomatic cases, must therefore be multiplied by 4 to provide a total number of imported dengue cases in France: [approximately equal to] 33,000 cases for the 2007-2010 period, including 1,300 cases in the area where the competent vector was established and during its period of activity. However, the role of asymptomatic dengue cases in the transmission of the virus to the competent vector is still not well known. In other words, viremia could be lower and shorter in duration in asymptomatic persons than in their symptomatic counterparts (31) and it is not certain that viremia of asymptomatic or mildly symptomatic persons is sufficient to be infective. From a public health point of view, the routine detection of asymptomatic infections returning from abroad is inconceivable.
Completeness of the 2 national-level surveillance systems differed greatly: [approximately equal to] 10% for mandatory notification and [approximately equal to] 40% for the laboratory network. For both surveillance systems, completeness was much higher in the area where the competent vector was established, and during the vector's period of activity; these factors represent the main target of the surveillance system. Although this finding is comforting in terms of ensuring the implementation of measures aimed at limiting the risk for a local cycle transmission, additional efforts should be made to further increase completeness. The low completeness level of mandatory notification brings up the question of its real usefulness for the early detection of cases and the implementation of control measures, especially because it only marginally improves the completeness of the laboratory network. However, the mandatory notification system in France does monitor the trends of imported cases, including those from countries where no dengue surveillance systems are in place, as is the case in most countries in western Africa (32). Furthermore, the mandatory notification system collects additional clinical information (symptoms, severity) which can be analyzed according to the serotype. This system is especially useful for surveillance of severe cases.
The laboratory network system is used for the monitoring of spatial and temporal trends of dengue fever among travelers, and the assessment of the risk for importation into metropolitan France, including areas where the vector is already established or is likely to become established. In our study, the observed geographic origin of imported cases can probably be simultaneously explained by the global epidemiology of dengue, traveler flows to France, and the practices used to request laboratory diagnosis. Travelers returning from Antilles during intense dengue epidemics were among those who introduced the greatest number of cases. Such a situation may recur more frequently in the future as the epidemiology of dengue continues to become hyperendemic in these territories (19). Furthermore, the number of imported cases may increase because of the expansion of dengue and the increase of travelers.
The third system, enhanced surveillance, completes the framework. It contributes to the detection of a few additional cases that were not detected by the other 2 surveillance systems. The enhanced surveillance system leads to faster detection of the great majority of cases in the areas where Ae. albopictus mosquitoes were found compared with the 2 other surveillance systems. It results in the immediate implementation of local control measures. Moreover, this local enhanced surveillance supports the annual mobilization of professionals during the vector activity period, including health stakeholders in the areas where the vector is expanding.
We thank Henriette de Valk for reviewing the manuscript. We thank the reporting physicians for providing mandatory notification, and the staff of the 6 laboratories forming the network: the national reference laboratories for arboviruses (Institut Pasteur in Paris, Institute for Biomedical Research of the Armies in Marseille), nationwide private laboratories (Cerba laboratory in Paris area, Biomnis laboratory in Lyon), and hospital laboratories (Avicenne hospital in Paris area, La Timone hospital in Marseille). We also thank Jude Sweeney for the English revision and editing of the manuscript.
Dr La Ruche is an epidemiologist at the Department of Infectious Diseases, French Institute for Public Health Surveillance, France. His research interests include surveillance and epidemiology of tropical infectious diseases and of sexually transmitted diseases.
(1.) World Health Organization. Dengue guidelines for diagnosis, treatment, prevention and control. Geneva: The Organization and the Special Programme for Research and Training in Tropical Diseases; 2009 [cited 2013 Sep 10]. http://whqlibdoc.who.int/ publications/2009/9789241547871_eng.pdf
(2.) Delaunay P, Mathieu B, Marty P, Fauran P, Schaffner F. Chronology of the development of Aedes albopictus in the Alpes-Maritimes Department of France, from 2002 to 2005 [in French]. Med Trop (Mars). 2007; 67:310-1.
(3.) French Health Ministry. Implementation of the plan against the spread of chikungunya and dengue viruses in metropolitan France [in French.] 2012; 168:2012-114 [cited 2013 Sep 10]. http:// circulaire.legifrance.gouv.fr/pdf/2012/05/cir_35302.pdf
(4.) La Ruche G, Souares Y, Armengaud A, Peloux-Petiot F, Delaunay P, Despres P, et al. First two autochthonous dengue virus infections in metropolitan France, September 2010. Euro Surveill. 2010; 15:19676.
(5.) Gjenero-Margan I, Aleraj B, Krajcar D, Lesnikar V, Klobucar A, Pem-Novosel I, et al. Autochthonous dengue fever in Croatia, August-September 2010. Euro Surveill. 2011; 16:19805.
(6.) Dejour Salamanca D, La Ruche G, Tarantola A, Souares Y, Armengaud A, Peloux-Petiot F, et al. Reported dengue cases in metropolitan France 2006-2008: need for the improvement of reporting [in French]. Bull Epidemiol Hebdo. 2010; 11:101-4 [cited 2013 Sep 10]. http://opac.invs.sante.fr/doc_num.php?explnum_id=443
(7.) Millar T, Domingo-Salvany A, Eastwood C, Hay G. Glossary of terms relating to capture-recapture methods. J Epidemiol Community Health. 2008; 62:677-81. http://dx.doi.org/10.1136/jech.2007.070433
(8.) La Ruche G, Dejour-Salamanca D, Debruyne M, Leparc-Goffart I, Ledrans M, Grandadam M, et al. Laboratory surveillance of dengue and chikungunya cases imported in metropolitan France 2008-2009 [in French]. Bull Epidemiol Hebdo. 2010; 31-32:325-9 [cited 2013 Sep 10]. http://opac.invs.sante.fr/doc_num.php?explnum_id=269
(9.) Ledrans M, Dejour-Salamanca D. Imported dengue and chikungunya infections in metropolitan France: surveillance from laboratory data, April 2005-December 2007 [in French]. French Institute for Public Health Surveillance, 2008 [cited 2013 Sep 10]. http://www. invs.sante.fr/publications/2008/cas_importes_chik_dengue/cas_importes_chic_dengue.pdf
(10.) Wittes J, Sidel VW. A generalization of the simple capture-recapture model with applications to epidemiological research. J Chronic Dis. 1968; 21:287-301. http://dx.doi.org/10.1016/0021-9681(68)90038-6
(11.) Wittes JT, Colton T, Sidel VW. Capture-recapture methods for assessing the completeness of case ascertainment when using multiple information sources. J Chronic Dis. 1974; 27:25-36. http://dx.doi.org/10.1016/0021-9681(74)90005-8
(12.) Chapman DG. Some properties of the hypergeometric distribution with applications to the zoological sample censuses. Berkeley (CA): University of California Press; 1951, 1:1060-7.
(13.) Seber GA. The effect of trap response on tag recapture estimates. Biometrics. 1970; 26:13-22. http://dx.doi.org/10.2307/2529040
(14.) Brittain S, Bohning D. Estimators in capture-recapture studies with two sources. Advances in Statistical Analysis. 2009; 93:23-47. http://dx.doi.org/10.1007/s10182-008-0085-y
(15.) Chao A. Estimating the population size for capture-recapture data with unequal catchability. Biometrics. 1987; 43:783-91. http://dx.doi.org/10.2307/2531532
(16.) Chao A. Estimating population size for sparse data in capture-recapture experiments. Biometrics. 1989; 45:427-38. http://dx.doi. org/10.2307/2531487
(17.) Cire Antilles-Guyane (regional office of the French Institute for Public Health Surveillance). Contributions of virological, clinical, epidemiological, socio-behavioral and mathematical modeling to control dengue in the French departments of America [in French]. Health surveillance bulletin. 2009; 3 [cited 2013 Sep 10]. http://www.invs. sante.fr/publications/bvs/antilles_guyane/2009/bvs_ag_2009_03.pdf
(18.) Cire Antilles-Guyane. Dengue in the French West Indies. Assessment of epidemics in 2010 [in French]. Health surveillance bulletin. 2011; 9-10 [cited 2013 Sep 10]. http://www.invs.sante.fr/fr/content/ download/26778/143249/version/13/file/bvs_ag_2011_09-10.pdf
(19.) Quenel P, Rosine J, Cassadou S, Ardillon V, Blateau A, Matheus S, et al. Epidemiology of dengue in the French overseas departments of the Americas [in French]. Bull Epidemiol Hebdo. 2011; 33-34:358-63 [cited 2013 Sep 10]. http://opac.invs.sante.fr/doc_num. php?explnum_id=7351
(20.) Tarantola A, Quatresous I, Ledrans M, Lassel L, Krastinova E, Cordel H, et al. Imported cases of dengue fever diagnosed in metropolitan France, from January 2001 to December 2006 [in French]. Med Mal Infect. 2009; 39:41-7. http://dx.doi.org/10.1016/j.medmal.2008.09.005
(21.) Krastinova E, Quatresous I, Tarantola A. Imported cases of chikungunya in metropolitan France: update to June 2006. Euro Surveill. 2006; 11:E060824.1.
(22.) Frank C, Schoneberg I, Krause G, Claus H, Ammon A, Stark K. Increase in imported dengue, Germany, 2001-2002. Emerg Infect Dis. 2004; 10:903-6. http://dx.doi.org/10.3201/eid1005.030495
(23.) Hook EB, Regal RR. Capture-recapture methods in epidemiology: methods and limitations. Epidemiol Rev. 1995; 17:243-64.
(24.) Gallay A, Vaillant V, Bouvet P, Grimont P, Desenclos JC. How many foodborne outbreaks of Salmonella infection occurred in France in 1995? Application of the capture-recapture method to three surveillance systems. Am J Epidemiol. 2000; 152:171-7. http:// dx.doi.org/10.1093/aje/152.2.171
(25.) Thandrayen J, Wang Y Capture-recapture analysis with a latent class model allowing for local dependence and observed heterogeneity. Biom J. 2010; 52:552-61. http://dx.doi.org/10.1002/bimj.200900051
(26.) Hassel M, Asbjernslett BE, Hole LP Underreporting of maritime accidents to vessel accident databases. Accid Anal Prev. 2011; 43:2053-63. http://dx.doi.org/10.1016j.aap.2011.05.027
(27.) Peragallo MS, Urbano F, Lista F, Sarnicola G, Vecchione A. Evaluation of cancer surveillance completeness among the Italian army personnel, by capture-recapture methodology. Cancer Epidemiol. 2011; 35:132-8. http://dx.doi.org/10.1016Zj.canep.2010. 06.016
(28.) Hook EB, Regal RR. Effect of variation in probability of ascertainment by sources ("variable catchability") upon "capture-recapture" estimates of prevalence. Am J Epidemiol. 1993; 137:1148-66.
(29.) Endy TP, Anderson KB, Nisalak A, Yoon IK, Green S, Rothman AL, et al. Determinants of inapparent and symptomatic dengue infection in a prospective study of primary school children in Kamphaeng Phet, Thailand. PLoS Negl Trop Dis. 2011; 5:e975. http://dx.doi. org/10.1371/journal.pntd.0000975
(30.) Porter KR, Beckett CG, Kosasih H, Tan RI, Alisjahbana B, Rudiman PI, et al. Epidemiology of dengue and dengue hemorrhagic fever in a cohort of adults living in Bandung, West Java, Indonesia. Am J Trop Med Hyg. 2005; 72:60-6.
(31.) Wilder-Smith A, Chen LH, Massad E, Wilson ME. Threat of dengue to blood safety in dengue-endemic countries. Emerg Infect Dis. 2009; 15:8-11. http://dx.doi.org/10.3201/eid1501.071097
(32.) La Ruche G, Renaudat C, Tarantola A, Caro V, Ledrans M, Dejour-Salamanca D, et al. Increase in dengue fever imported from Cote d'Ivoire and West Africa to France. Dengue Bull. 2010; 34:24-31 [cited 2013 Feb 27]. http://220.127.116.11/LinkFiles/Dengue_Bulletins_3-vol34.pdf.
Author affiliations: Institut de Veille Sanitaire, Saint-Maurice, France (G. La Ruche, D. Dejour-Salamanca, P. Bernillon, M. Gastellu-Etchegorry); Institut de Recherche Biomedicale des Armees, Marseille, France (I. Leparc-Goffart); Cellule de l'Institut de Veille Sanitaire aux Antilles-Guyane, Fort-de-France, Martinique, France (M. Ledrans) ; Cellule de l'Institut de Veille Sanitaire Sud, Marseille (A. Armengaud); Cerba Laboratory, Saint-Ouen l'Aumone, France (M. Debruyne); Biomnis Laboratory, Lyon, France (G.-A. Denoyel); Avicenne University Hospital, Bobigny, France (S. Brichler); Institut Hospitalo-Universitaire Mediterranee-Infection, Marseille (L. Ninove); and Institut Pasteur National Reference Laboratory for Arboviruses, Paris, France (P. Despres)
DOI: http://dx.doi.org/ 10.3201/eid19011.120624
Address for correspondence: Guy La Ruche, 12 rue du Val d'Osne, 94415 Saint-Maurice Cedex, France; email: email@example.com
Table 1. Interdependence of laboratory network, mandatory notification, and enhanced surveillance systems in the detection of dengue cases, southeast France, May 1-November 30, 2010 Laboratory network Odds ratio Surveillance system Included Not included (95% Cl *) Mandatory notification 0.7 (0.3-1.9) Included 74 13 Not included 74 9 Enhanced surveillance 17.1 (1.2-907.9) Included 74 13 Not included 1 3 Enhanced surveillance Odds ratio Surveillance system Included Not included (95% Cl*) Mandatory notification 25.0 (3.8-1040.0) Included 74 1 Not included 74 25 Enhanced surveillance Included Not included * 95% CI calculated using exact confidence limits. Table 2. Annual number of dengue cases estimated from mandatory notification and laboratory network surveillance systems by using Chao estimator, stratified according to geographic area and period of the year, metropolitan France, 2007-2010 * No. observed cases Chao estimator System Common Estimated no. cases Year, region, period MN LN cases (95% CI) 2007 Southeast, May-Nov 4 21 4 39 (26-87) Other areas, remainder 52 365 21 2,070 (1,444-3,071) of year Total 56 386 25 2,109 (1,481-3,109) 2008 Southeast, May-Nov 6 11 4 18 (14-37) Other areas, remainder 58 293 42 733 (595-938) of year Total 64 304 46 751 (613-956) 2009 Southeast, May-Nov 5 19 4 36 (24-79) Other areas, remainder 63 331 38 1,021 (806-1,339) of year Total 68 350 42 1,057 (841-1,375) 2010 Southeast, May-Nov 91 174 75 234 (216-264) Other areas, remainder 494 1,951 354 4,222 (3,932-4,558) of year Total 585 2,125 429 4,456 (4,164-4,792) 2007-2010 Southeast, May-Nov 106 225 87 327 (294-382) Other areas, remainder 667 2,940 455 8,047 (7,217-9,045) of year Total 773 3,165 542 8,374 (7,543-9,371) Chao estimator Completeness of Completeness of Year, region, period MN, % (95% CI) LN, % (95% CI) 2007 Southeast, May-Nov 10.2 (2.4-17.2) 53.8 (12.6-90.4) Other areas, remainder 2.5 (1.6-3.9) 17.6 (10.9-27.1) of year Total 2.7 (1.6-4.0) 18.3 (11.3-27.5) 2008 Southeast, May-Nov 33.2 (7.6-44.8) 60.9 (13.9-82.2) Other areas, remainder 7.9 (5.9-10.0) 40.0 (30.0-50.6) of year Total 8.5 (6.3-10.6) 40.5 (29.8-50.5) 2009 Southeast, May-Nov 13.9 (3.1-22.9) 52.8 (11.6-87.2) Other areas, remainder 6.2 (4.5-8.1) 32.4 (23.7-42.4) of year Total 6.4 (4.6-8.2) 33.1 (23.6-42.4) 2010 Southeast, May-Nov 38.9 (33.2-42.7) 74.3 (63.6-81.6) Other areas, remainder 11.7 (10.8-12.6) 46.2 (42.7-49.7) of year Total 13.1 (12.2-14.1) 47.7 (44.2-51.1) 2007-2010 Southeast, May-Nov 32.4 (17.2-35.7) 68.8 (36.5-75.8) Other areas, remainder 8.3 (7.1-9.2) 36.5 (31.1-40.7) of year Total 9.2 (8.2-10.7) 37.8 (33.5-43.8) * Information on geographic area or period of the year was not available for 27 cases. MN, mandatory notification; LN, laboratory network. Table 3. Annual number of dengue cases estimated from MN and LN surveillance systems by using Chapman-Seber estimator, stratified according to geographic area and period of the year, metropolitan France, 2007-2010 * No. observed cases System Common Estimated no. cases Year, region, period MN LN cases (95% CI) 2007 Southeast, May-Nov 4 21 4 21 ([dagger]) Other areas, remainder 52 365 21 881 (678-1,228) of year Total 56 386 25 902 (699-1,249) 2008 Southeast, May-Nov 6 11 4 16 (14-27) Other areas, remainder 58 293 42 402 (360-479) of year Total 64 304 46 418 (376-495) 2009 Southeast, May-Nov 5 19 4 23 (20-38) Other areas, remainder 63 331 38 544 (468-671) of year Total 68 350 42 567 (490-694) 2010 Southeast, May-Nov 91 174 75 211 (200-232) Other areas, remainder 494 1,951 354 2,721 (2,599-2,872) of year Total 585 2,125 429 2,932 (2,809-3,083) 2007-2010 Southeast, May-Nov 106 225 87 271 (258-294) Other areas, remainder 667 2,940 455 4,548 (4,262-4,907) of year Total 773 3,165 542 4,818 (4,532-5,178) Chapman-Seber estimator Completeness of Completeness of Year, region, period MN, % (95% CI) LN, % (95% CI) 2007 Southeast, May-Nov 19.0 ([dagger]) 100 ([dagger]) Other areas, remainder 5.9 (4.2-7.7) 41.4 (29.7-53.8) of year Total 6.2 (4.5-8.0) 42.8 (30.9-55.2) 2008 Southeast, May-Nov 38.0 (22.0-44.4) 69.6 (40.3-81.2) Other areas, remainder 14.4 (12.1-16.1) 72.8 (61.2-81.3) of year Total 15.3 (12.9-17.0) 72.7 (61.2-80.7) 2009 Southeast, May-Nov 21.7 (13.1-24.4) 82.6 (52.3-97.6) Other areas, remainder 11.6 (9.4-13.5) 60.9 (49.3-70.1) of year Total 12.0 (9.8-13.8) 61.7 (50.3-71.2) 2010 Southeast, May-Nov 43.2 (39.3-45.4) 82.5 (75.2-86.8) Other areas, remainder 18.2 (17.2-19.0) 71.7 (67.9-75.1) of year Total 20.0 (19.0-20.8) 72.5 (68.9-75.6) 2007-2010 Southeast, May-Nov 39.2 (35.4-40.8) 83.1 (75.1-86.7) Other areas, remainder 14.7 (13.5-15.5) 64.6 (59.3-68.5) of year Total 16.0 (14.8-16.9) 65.7 (60.5-69.3) * Information on geographic area or period of the year was not available for 27 cases; MN, mandatory notification; LN, laboratory network. ([dagger]) 95% CI not presented because of null variances. Table 4. Number of dengue cases estimated from mandatory notification and laboratory network surveillance systems with Chao estimator after stratification according to geographic area and period of the year, metropolitan France, in 2010 and for 2007-2010 * No. observed cases With With Common Stratification type, Y MN LN cases Geographic stratification 2010 Southeast 97 229 80 Other areas 488 1,896 349 Total 585 2,125 429 2007-2010 Southeast 113 320 93 Other areas 660 2,847 449 Total 773 3,167 542 Period stratification 2010 May-Nov ([dagger]) 524 1,694 386 Remainder of year 61 431 43 Total 585 2,125 429 2007-2010 May-Nov 656 2,325 468 Remainder of year 117 865 74 Total 773 3,190 542 Estimated total no. Completeness of Stratification type, Y cases (95% CI) MN, % (95% CI) Geographic stratification 2010 Southeast 332 (302-378) 29.2 (25.0-32.5) Other areas 4,071 (3,791-4,396) 12.0 (11.1-12.9) Total 4,403 (4,120-4,730) 13.3 (12.3-14.2) 2007-2010 Southeast 558 (475-691) 20.3 (16.3-23.8) Other areas 7,684 (6,896-8,632) 8.6 (7.6-9.6) Total 8,242 (7,446-9,194) 9.4 (8.4-10.4) Period stratification 2010 May-Nov ([dagger]) 3,186 (2,994-3,410) 16.4 (15.3-17.5) Remainder of year 1,407 (1,118-1,821) 4.3 (3.2-5.6) Total 4,594 (4,223-5,034) 12.7 (11.4-13.9) 2007-2010 May-Nov 5,263 (4,764-5,873) 12.5 (11.4-13.9) Remainder of year 3,416 (2,761-4,303) 3.4 (2.7-4.2) Total 8,679 (7,817-9,709) 8.9 (8.0-9.9) Combined Completeness of completeness, % Stratification type, Y LN, % (95% CI) (95% CI) Geographic stratification 2010 Southeast 69.0 (59.0-76.8) 74.1 (63.4-82.5) Other areas 46.6 (43.1-50.0) 50.0 (46.2-53.8) Total 48.3 (44.8-51.6) 51.8 (48.1-55.4) 2007-2010 Southeast 57.3 (46.3-67.3) 60.9 (49.2-71.5) Other areas 37.1 (32.9-41.2) 39.8 (35.3-44.3) Total 38.4 (34.4-42.5) 41.2 (37.0-45.6) Period stratification 2010 May-Nov ([dagger]) 53.2 (49.6-56.6) 57.5 (53.6-61.3) Remainder of year 30.6 (22.9-39.6) 31.9 (23.8-41.2) Total 46.3 (41.5-50.4) 49.7 (44.6-54.1) 2007-2010 May-Nov 44.2 (39.6-48.8) 47.7 (42.8-52.8) Remainder of year 25.3 (20.1-31.3) 26.6 (21.1-32.9) Total 36.8 (32.9-40.8) 39.4 (35.2-43.8) * MN, mandatory notification; LN, laboratory network; information on geographic area or period of the year was not available for 27 cases. Southeast includes the departments (administrative regions) where the competent vector, the Aedes albopictus mosquito, was established. ([dagger]) May-Nov is the period of activity of Ae. albopictus mosquitoes in metropolitan France. Table 5. Geographic area of acquisition (%) among patients with dengue infection in metropolitan France, 2007-2010 * Region ([dagger]) 2007 (n = 109) 2008 (n = 119) 2009 (n = 151) Africa Central 2.8 0.8 0.7 East 6.4 1.7 0.7 West 4.6 21.8 11.9 Americas Caribbean 42.2 22.7 19.9 Central America 3.7 3.4 4.0 South America 8.3 5.9 13.9 Asia Central 6.4 7.6 8.6 Southeast 20.2 28.6 32.5 South Pacific Polynesia 5.5 7.6 6.0 Other areas in 0.0 0.0 2.0 the South Pacific Region ([dagger]) 2010 (n = 956) 2007-2010 (n = 1,335) Africa Central 0.6 0.8 East 2.6 2.6 West 1.8 4.9 Americas Caribbean 75.0 61.4 Central America 0.4 1.3 South America 2.8 4.8 Asia Central 3.9 4.9 Southeast 12.8 17.0 South Pacific Polynesia 0.0 1.8 Other areas in 0.1 0.3 the South Pacific * Information was available for mandatory notification and for 3 of the 6 laboratories involved in the surveillance network. ([dagger]) Geographic regions and subregions: United Nations Statistics Division (http://unstats.un.org/unsd/methods/m49/m49regin.htm)._
|Printer friendly Cite/link Email Feedback|
|Author:||La Ruche, Guy; Dejour-Salamanca, Dominique; Bernillon, Pascale; Leparc-Goffart, Isabelle; Ledrans, M|
|Publication:||Emerging Infectious Diseases|
|Date:||Nov 1, 2013|
|Previous Article:||Atypical scrapie prions from sheep and lack of disease in transgenic mice overexpressing human prion protein.|
|Next Article:||Pseudorabies virus variant in Bartha-K61-vaccinated pigs, China, 2012.|